Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru

Descripción del Articulo

ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA)...

Descripción completa

Detalles Bibliográficos
Autores: Méndez Chacón, Pedro, Bardales, Fernando, Chunga, Ausberto, Méndez Chacón, Carla, Vidalón Fernández, Armando, Diekmann, Fritz, Oppenheimer, Federico, Campistol, Josep María
Formato: artículo
Fecha de Publicación:2017
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/13222
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222
Nivel de acceso:acceso abierto
Materia:ABO Incompatible
Trasplante Renal
Acomodación
Anticuerpos anti HLA
Riesgo Inmunológico.
ABO Incompatibility
Kidney Transplantation
Accommodation
HLA antibodies
Immunological Risk.
id REVUNMSM_11108bc84bda55b62736d939bb1f3ff4
oai_identifier_str oai:ojs.csi.unmsm:article/13222
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
spelling Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and PeruTrasplante renal grupo sanguíneo ABO incompatible. Experiencia colaborativa inédita España y PerúMéndez Chacón, PedroBardales, FernandoChunga, AusbertoMéndez Chacón, CarlaVidalón Fernández, ArmandoDiekmann, FritzOppenheimer, FedericoCampistol, Josep MaríaABO IncompatibleTrasplante RenalAcomodaciónAnticuerpos anti HLARiesgo Inmunológico.ABO IncompatibilityKidney TransplantationAccommodationHLA antibodiesImmunological Risk.ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA) 89% kidney retransplantation patient, who lacked any option to get a cadaveric or family donor. However, the patient’s sole HLA-compatible living donor had group A blood incompatible with the recipient’s O blood group. The patient required a pre-conditioning regime that consisted of plasma exchange, rituximab, immunoglobulin, and quadruple immunosuppressive therapy in order to reduce high titers of anti-A isoagglutinins from 1:128 to a safe level of 1:8, for successful transplant. This was performed in coordination with the Renal Transplant Unit of Hospital Clinic de Barcelona (HCB), Spain. Absence of rejection mediated by isoagglutinins shows the potential benefit of a protocol consisting in removing antibodies from the anti-blood group. Two years after transplantation, the kidney function remains stable, with creatinine levels of 1.5 mg%. We conclude that an ABO-incompatible kidney transplant is a viable option for patients whose only donor has blood of an incompatible blood group and for us this represents a hope-inspiring source of organs.La incompatibilidad de grupo sanguíneo ABO y la sensibilización al HLA constituyen grandes barreras a vencer en pro de la óptima utilización de riñones de donante vivo. Describimos en nuestro medio el primer trasplante renal exitoso ABO incompatible en un paciente de 24 años, retrasplantado renal, altamente sensibilizado (PRA: 89%) y sin opción alguna en disponer de donantes cadavéricos ni familiares. Sin embargo, su único donante vivo HLA compatible era de grupo sanguíneo A incompatible con el grupo O del receptor. El paciente requirió de un régimen precondicionante consistente en recambios plasmáticos, rituximab, imunoglobulina y terapia inmunosupresora cuádruple, a fin de reducir los títulos elevados de isoaglutininas anti A de 1:128 a niveles de seguridad de 1:8, para el éxito del trasplante. Este fue realizado en Coordinación con la Unidad de Trasplante Renal del Hospital Clínic de Barcelona España (HCB). La ausencia de rechazo mediado por isoaglutininas muestra el potencial beneficio del protocolo al remover los anticuerpos anti grupo sanguíneo. A los dos años del trasplante, la función renal se mantiene estable con niveles de creatinina 1,5 mg%. Concluimos que el trasplante renal ABO incompatible (ABOi) es opción viable para pacientes cuyo único donante sea grupo sanguíneo incompatible, y entre nosotros representa esperanzadora fuente de órganos.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2017-07-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1322210.15381/anales.v78i2.13222Anales de la Facultad de Medicina; Vol. 78 No. 2 (2017); 224-229Anales de la Facultad de Medicina; Vol. 78 Núm. 2 (2017); 224-2291609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222/12353Derechos de autor 2017 Pedro Méndez Chacónhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/132222017-11-21T08:48:35Z
dc.title.none.fl_str_mv Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
Trasplante renal grupo sanguíneo ABO incompatible. Experiencia colaborativa inédita España y Perú
title Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
spellingShingle Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
Méndez Chacón, Pedro
ABO Incompatible
Trasplante Renal
Acomodación
Anticuerpos anti HLA
Riesgo Inmunológico.
ABO Incompatibility
Kidney Transplantation
Accommodation
HLA antibodies
Immunological Risk.
title_short Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
title_full Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
title_fullStr Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
title_full_unstemmed Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
title_sort Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
dc.creator.none.fl_str_mv Méndez Chacón, Pedro
Bardales, Fernando
Chunga, Ausberto
Méndez Chacón, Carla
Vidalón Fernández, Armando
Diekmann, Fritz
Oppenheimer, Federico
Campistol, Josep María
author Méndez Chacón, Pedro
author_facet Méndez Chacón, Pedro
Bardales, Fernando
Chunga, Ausberto
Méndez Chacón, Carla
Vidalón Fernández, Armando
Diekmann, Fritz
Oppenheimer, Federico
Campistol, Josep María
author_role author
author2 Bardales, Fernando
Chunga, Ausberto
Méndez Chacón, Carla
Vidalón Fernández, Armando
Diekmann, Fritz
Oppenheimer, Federico
Campistol, Josep María
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ABO Incompatible
Trasplante Renal
Acomodación
Anticuerpos anti HLA
Riesgo Inmunológico.
ABO Incompatibility
Kidney Transplantation
Accommodation
HLA antibodies
Immunological Risk.
topic ABO Incompatible
Trasplante Renal
Acomodación
Anticuerpos anti HLA
Riesgo Inmunológico.
ABO Incompatibility
Kidney Transplantation
Accommodation
HLA antibodies
Immunological Risk.
description ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA) 89% kidney retransplantation patient, who lacked any option to get a cadaveric or family donor. However, the patient’s sole HLA-compatible living donor had group A blood incompatible with the recipient’s O blood group. The patient required a pre-conditioning regime that consisted of plasma exchange, rituximab, immunoglobulin, and quadruple immunosuppressive therapy in order to reduce high titers of anti-A isoagglutinins from 1:128 to a safe level of 1:8, for successful transplant. This was performed in coordination with the Renal Transplant Unit of Hospital Clinic de Barcelona (HCB), Spain. Absence of rejection mediated by isoagglutinins shows the potential benefit of a protocol consisting in removing antibodies from the anti-blood group. Two years after transplantation, the kidney function remains stable, with creatinine levels of 1.5 mg%. We conclude that an ABO-incompatible kidney transplant is a viable option for patients whose only donor has blood of an incompatible blood group and for us this represents a hope-inspiring source of organs.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-17
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222
10.15381/anales.v78i2.13222
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222
identifier_str_mv 10.15381/anales.v78i2.13222
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222/12353
dc.rights.none.fl_str_mv Derechos de autor 2017 Pedro Méndez Chacón
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2017 Pedro Méndez Chacón
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 78 No. 2 (2017); 224-229
Anales de la Facultad de Medicina; Vol. 78 Núm. 2 (2017); 224-229
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238256196976640
score 13.873571
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).